Efficacy and Safety of BMS-986165 Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA)
Condition: Active Psoriatic Arthritis Interventions: Other: BMS-986165 Placebo; Drug: BMS-986165 Dose A; Drug: BMS-986165 Dose B; Drug: Ustekinumab; Other: Ustekinumab Placebo Sponsor: Bristol-Myers Squibb Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials